P396-0014 Screening compound: 1-(3-{[3-(dimethylamino)-2-pyrazinyl]oxy}-1-pyrrolidinyl)-4-(4-fluorophenyl)-1,4-butanedione

P396-0014 Screening compound: 1-(3-{[3-(dimethylamino)-2-pyrazinyl]oxy}-1-pyrrolidinyl)-4-(4-fluorophenyl)-1,4-butanedione
P396-0014 Screening compound: 1-(3-{[3-(dimethylamino)-2-pyrazinyl]oxy}-1-pyrrolidinyl)-4-(4-fluorophenyl)-1,4-butanedione alternative view

Chemical Structure Depiction of ChemDiv screening compound P396-0014
1-(3-{[3-(dimethylamino)-2-pyrazinyl]oxy}-1-pyrrolidinyl)-4-(4-fluorophenyl)-1,4-butanedione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P396-0014

Molecular Formula

C20H23FN4O3 (C20 H23 FN4 O3)

Compound Name

1-(3-{[3-(dimethylamino)-2-pyrazinyl]oxy}-1-pyrrolidinyl)-4-(4-fluorophenyl)-1,4-butanedione

IUPAC name

n/a

SMILES

CN(C)c1nccnc1OC(CC1)CN1C(CCC(c(cc1)ccc1F)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.962

Distribution Coefficient, logD

1.961

Water Solubility, LogSw

-2.22

Polar Surface Area

57.758

Acid Dissociation Constant (pKa)

20.69

Base Dissociation Constant (pKb)

3.82

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

P396-0014 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Targets:
  • GPCR
  • Ion Channels
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P396-0014 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P396-0014?
Check Price and Availability of P396-0014, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P396-0014 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P396-0014
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P396-0014
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P396-0014 available by request